Samsung Gets J&J Unit's UK Stelara Patent Invalidated
Samsung Bioepis on Tuesday persuaded a London court to invalidate Janssen's patent over its blockbuster Stelara drug, proving that the medicine is not inventive over a 2018 presentation on the medicine's...To view the full article, register now.
Already a subscriber? Click here to view full article